Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > DRONEDARONE HYDROCHLORIDE

DRONEDARONE HYDROCHLORIDE

pharmaceutical raw materials
DRONEDARONE HYDROCHLORIDE structure

DRONEDARONE HYDROCHLORIDE 

structure
  • CAS No:

    141625-93-6

  • Formula:

    C31H44N2O5S.ClH

  • Chemical Name:

    DRONEDARONE HYDROCHLORIDE

  • Synonyms:

    Multaq;N-(2-butyl-3-{4-[3-(dibutylaMino)propoxy]benzoyl}-1-benzofuran-5-yl)MethanesulfonaMide hydrochloride (1:1);N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-benzofuran-5-yl)methanesulfonamide hydrochlorid;Dronedarone Hydrocholoride;CS-132;Dronedarone hydrochloride, ≥98% (HPLC);N-[2-butyl-3-[4-(3-dibutyl-aminopropoxy) benzoyl] methanesulfonamide hydrochloride;SR-33589B

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Dronedarone hydrochloride is a non-iodinated amiodarone derivative that inhibits Na+, K+ and Ca2+ currents.


Pale Yellow Solid


DRONEDARONE HYDROCHLORIDE (brand name: Multaq) is an antiarrhythmic drug developed by Sanofi-Aventis. It was approved by the FDA in July 2009 for the treatment of atrial fibrillation and atrial flutter, reducing the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL). The drug was developed to create a treatment that maintains the therapeutic benefits of amiodarone while reducing associated serious side effects such as pulmonary toxicity and thyroid dysfunction. DRONEDARONE HYDROCHLORIDE is usually administered orally in tablet form. The recommended dose is 400 mg twice daily, one tablet in the morning and one in the evening.

DRONEDARONE HYDROCHLORIDE Basic Attributes

593.224

592.273743

630-355-2

FA36DV299Q

DTXSID30161779

white to off-white

2935904000

Characteristics

97.2

9.00480

white to off-white

NA (low-melting)

683.9ºC at 760mmHg

367.4ºC

DMSO: soluble15mg/mL, clear

Refrigerator

1.47E-18mmHg at 25°C

2-8°C

Safety Information

UN 3077 9 / PGIII

3

P201, P202, P260, P261, P263, P264, P270, P271, P273, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P330, P332+P313, P337+P313, P362, P391, P403+P233, P405, P501

H302

UN 3077 9 / PGIII

|Danger|H302 (33.33%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P261, P263, P264, P270, P271, P273, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P330, P332+P313, P337+P313, P362, P391, P403+P233, P405, and P501|Aggregated GHS information provided by 13 companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

DRONEDARONE HYDROCHLORIDE Use and Manufacturing

Uses

A drug used for the treatment of atrial fibrillation and atrial flutter in patients who have suffered cardiac arrhythmias.


Cardiovascular Drugs

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:593.2
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:18
Exact Mass:592.2737714
Monoisotopic Mass:592.2737714
Topological Polar Surface Area:97.2
Heavy Atom Count:40
Complexity:800
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Not yet clear

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • AURORE LIFE SCIENCES PRIVATE LTD

    United States United States
    Active
  • RAKS PHARMA PVT LTD

    United States United States
    Active
  • MSN LABORATORIES PRIVATE LTD

    United States United States
    Active

Recommended Suppliers of DRONEDARONE HYDROCHLORIDE

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.